Europe Infectious Disease Molecular Diagnostics Market Size & Outlook
The infectious disease molecular diagnostics market in Europe is expected to reach a projected revenue of US$ 4,784.9 million by 2030. A compound annual growth rate of 2.2% is expected of Europe infectious disease molecular diagnostics market from 2025 to 2030.
Clinical Diagnostics
In Vitro Diagnostics
Infectious Disease Molecular Diagnostics Market Outlook
Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp
Other key industry trends
In terms of revenue, Europe region accounted for 26.4% of the global infectious disease molecular diagnostics market in 2024.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Latin America is the fastest growing regional market and is projected to reach USD 1,034.5 million by 2030.
Increasing prevalence of infectious diseases coupled with growing investments in infectious disease diagnostics research initiatives, is expected to drive the market. However, the current European economic crisis and presence of uneven reimbursement policies act as market restraints.
In 2017, a new regulation was issued regarding IVD & medical devices in European countries, which is likely to be updated by 2022. The new regulation is expected to offer a more sustainable and robust framework for compliance of molecular diagnostic devices.
The launch of new molecular diagnostics tests is expected to boost Europe’s molecular diagnostics market. In April 2018, Curetis N.V. launched Unyvero UTI during European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Europe Infectious Disease Molecular Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Disease Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Reagents Product was the largest segment with a revenue share of 67.63% in 2024.
Horizon Databook has segmented the Europe infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of infectious diseases coupled with growing investments in infectious disease diagnostics research initiatives, is expected to drive the market. However, the current European economic crisis and presence of uneven reimbursement policies act as market restraints.
In 2017, a new regulation was issued regarding IVD & medical devices in European countries, which is likely to be updated by 2022. The new regulation is expected to offer a more sustainable and robust framework for compliance of molecular diagnostic devices.
The launch of new molecular diagnostics tests is expected to boost Europe’s molecular diagnostics market. In April 2018, Curetis N.V. launched Unyvero UTI during European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Europe Infectious Disease Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
Instruments Product
Reagents Product
Services Product
Europe Infectious Disease Molecular Diagnostics Market Test location Outlook (Revenue, USD Million , 2018-2030)
Hospitals
Clinics
Diagnostics Laboratories
Research Institutes
Europe Infectious Disease Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
Europe Infectious Disease Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
Respiratory Diseases
Tuberculosis
Meningitis
Gastrointestinal Tract Infections
HPV
Sexually Transmitted Infection
Sepsis
Drug Resistance Disease
Others Application
Reasons to subscribe to Infectious Disease Molecular Diagnostics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Infectious Disease Molecular Diagnostics Market Outlook databook
Our clientele includes a mix of Infectious Disease Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Infectious Disease Molecular Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Infectious Disease Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Europe Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)